TB-500 is a synthetic analogue of Thymosin Beta-4, a naturally occurring 43-amino-acid protein present in virtually every cell in the human body. The active fragment — specifically the actin-binding domain LKKTETQ — is responsible for the majority of TB-500's studied biological effects. Unlike full-length Thymosin Beta-4, TB-500 is a shorter, more bioavailable fragment that has become one of the most researched recovery peptides globally.
What Is TB-500?
TB-500 was first isolated and characterised in thymus tissue, giving rise to the "Thymosin" name. The peptide's primary mechanism involves sequestering G-actin monomers, which regulates the actin cytoskeleton — the structural scaffolding within cells that governs migration, adhesion, and division. By modulating actin dynamics, TB-500 facilitates rapid migration of endothelial cells, keratinocytes, and satellite muscle cells to sites of injury, dramatically accelerating tissue repair timelines.
Research has also shown that TB-500 upregulates cell surface receptors for growth factors including IGF-1 and HGH, creating a synergistic environment for anabolic repair processes. This dual action — structural (actin regulation) and signalling (receptor upregulation) — distinguishes TB-500 from simpler growth factors.
Key Research Applications
Muscle Repair and Delayed-Onset Muscle Soreness (DOMS)
Perhaps the most studied application of TB-500 is accelerated skeletal muscle repair. In preclinical models, TB-500 administration following acute muscle injury significantly reduced recovery time by promoting satellite cell activation and myoblast proliferation. Researchers studying exercise-induced damage have noted its potential to compress DOMS windows — the 24–72 hour inflammatory soreness following eccentric loading — by clearing damaged protein aggregates and restoring sarcomere integrity faster than natural repair alone.
This has made TB-500 a subject of intense interest among sports medicine researchers, particularly in contexts where rapid return to training is a study objective.
Angiogenesis
TB-500 is one of the few peptides with demonstrated pro-angiogenic activity in peer-reviewed literature. It promotes the formation of new blood vessels by stimulating endothelial cell migration and tube formation. In ischaemic tissue models, this translates to improved oxygen and nutrient delivery to injured areas. Angiogenesis is particularly relevant in tendon and ligament research, where the naturally poor vascular supply creates chronic healing challenges.
Tendon and Connective Tissue Research
Tendons present a uniquely difficult healing environment: low cellularity, minimal vascularity, and slow metabolic turnover mean injuries persist for months or years. TB-500's combination of angiogenic and cell-migratory effects has been investigated as a potential strategy to overcome these limitations. Studies in equine tendinopathy models — widely used as a translational proxy for human tendon biology — have shown promising results in tissue organisation and collagen fibre alignment.
Cardiac Tissue
A smaller but compelling body of research examines TB-500's role in cardiac repair following ischaemia. Thymosin Beta-4 was found to reactivate epicardial progenitor cells that are otherwise quiescent in adult mammals, suggesting a regenerative pathway that has attracted significant academic interest.
Dosage Protocol
Standard research dosage: 2–2.5 mg administered twice per week
Loading phase: Some protocols specify a higher loading period of 4–6 weeks at 2–2.5 mg twice weekly, followed by a maintenance phase of 2 mg once per week
Half-life: Estimated at several hours; exact pharmacokinetics in humans remain under investigation
Administration: Subcutaneous or intramuscular injection following reconstitution with bacteriostatic water. Use our BAC water calculator to determine the precise volume of bacteriostatic water needed for your target concentration before reconstituting any vial.
Storage and Reconstitution
Lyophilised TB-500 is stable at room temperature for short periods but should be stored at -20°C for long-term preservation. Once reconstituted with bacteriostatic water, refrigerate at 2–8°C and use within 4 weeks. Reconstitution should be performed by directing the bacteriostatic water gently down the inside wall of the vial — never inject directly onto the lyophilised cake, as mechanical disruption can fragment the peptide structure. Before drawing your reconstitution volume, use the BAC calculator to calculate the exact millilitres required per dose.
TB-500 and BPC-157: The Recovery Stack
TB-500 is frequently studied alongside BPC-157 as a complementary recovery stack. While TB-500 primarily promotes cell migration and angiogenesis, BPC-157 acts through the nitric oxide and growth hormone receptor pathways to accelerate healing at the cellular signalling level. The two mechanisms are largely orthogonal, making them a natural pairing in multi-modal recovery research protocols. Many researchers begin with TB-500 at 2 mg twice weekly and BPC-157 at 250–500 mcg daily to study the combined effect on acute musculoskeletal injuries.
Where to Buy TB-500 in India
Peptide Central stocks TB-500 at 99% purity, independently HPLC-verified with a full Certificate of Analysis included with every order. Available in 5 mg vials with pan-India COD delivery. We are the only Indian vendor offering in-house third-party verification documentation as standard — not on request.
99% HPLC-verified purity, COA included, pan-India COD delivery. Message us on WhatsApp for pricing and availability.
Order on WhatsApp